Modelling cancer metabolism in vitro : current improvements and future challenges - CRCL-Métabolisme du gliolastome et hétérogénéité tumorale Accéder directement au contenu
Article Dans Une Revue FEBS Journal Année : 2022

Modelling cancer metabolism in vitro : current improvements and future challenges

Résumé

Advances in cancer biology over the past decades have revealed that metabolic adaptation of cancer cells is an essential aspect of tumorigenesis. However, recent insights into tumour metabolism in vivo have revealed dissimilarities with results obtained in vitro. This is partly due to the reductionism of in vitro cancer models that struggle to reproduce the complexity of tumour tissues. This review describes some of the discrepancies in cancer cell metabolism between in vitro and in vivo conditions, and presents current methodological approaches and tools used to bridge the gap with the clinically relevant microenvironment. As such, these approaches should generate new knowledge that could be more effectively translated into therapeutic opportunities.
Fichier principal
Vignette du fichier
Dragic et al. revised _HD for HAL.pdf (488 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04132220 , version 1 (28-06-2023)

Identifiants

Citer

Helena Dragic, Cedric Chaveroux, Erika Cosset, Serge N Manie. Modelling cancer metabolism in vitro : current improvements and future challenges. FEBS Journal, 2022, ⟨10.1111/febs.16704⟩. ⟨hal-04132220⟩
17 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More